Advanced Search

 

Study ID Status Title Patient Level Data
FMS30042 Completed A Multi-centre, Randomised, Double-Blind, Parallel-Group Study to Compare the Efficacy and Safety of Fluticasone Propionate 100?g bd (200?g Daily) Produced by Two Recrystallisation Processes (“Old Process” “New Process”) Administered Via Dry Powder Inhaler, and With “New Process” Fluticasone Pro ...
FMS30043 Completed A Multicentre, Double-Blind, Randomised, Four-Week, Parallel-Group Comparison of Fluticasone Propionate 100?g bd (200?g/day) with Beclomethasone Dipropionate 200?g bd (400?g/day) in Adult Patients with Mild to Moderate Asthma
FMS30044 Completed An Open Study to Assess the Long-Term Safety of Fluticasone Propionate 50?g bd (100?g/day) or 100?g bd (200?g/day) in Children, Aged 6-16 Years, with Moderately Severe Asthma
FMS30045 Completed A Double-Blind, Parallel-Group Study to Investigate the Clinical Safety and Efficacy of Fluticasone Propionate, 50?g bd (100?g/day), Compared with Placebo in the Management of Moderately Severe Chronic Asthma in Children, Aged 6-12 Years
FMS30047 Completed Study to Assess Long-Term Tolerability and Safety of Fluticasone Propionate in Severe Chronic Asthma
FMS30048 Completed A Multicentre, Double-Blind, Randomised, Six-Week, Parallel-Group Study to Compare the Efficacy and Safety of Fluticasone Propionate 500?g bd (1000?g Daily) with Beclomethasone Dipropionate 1000?g bd (2000?g Daily) in Adult Patients with Severe Asthma
FMS30049 Completed A Multicentre, Double-Blind, Randomised, Four-Week, Parallel-Group, Comparison of Inhaled Fluticasone Propionate and Inhaled Beclomethasone Dipropionate in Patients with Severe Asthma Controlled by High-Dose Inhaled Corticosteroids
FMS30052 Completed A Multicentre, Randomised, Double-Blind, Parallel-Group Study to Compare the Efficacy and Safety of Fluticasone Propionate 100µg bd (200µg Daily) with Beclomethasone Dipropionate 200µg bd (400µg Daily) Administered Via a Pressurised Inhaler in the Management of Childhood Asthma
FMS30053 Completed A Multi-Centre, Randomised, Double-Blind, Parallel-Group Study to Compare the Efficacy and Safety of Fluticasone Propionate 50?g BD (100?g Daily) with Fluticasone Propionate 100?g BD (200?g Daily), Each Administered as a Dry Powder Formulation, in Children
FMS30054 Completed A Multicentre, Randomised, Double-Blind, Parallel-Group Study to Compare the Safety and Efficacy of Fluticasone Propionate 750µg bd (1500µg/Day) with that of Beclomethasone Dipropionate 750µg bd (1500µg/Day) in Geriatric Patients with Chronic Asthma
FMS30055 Completed A Multicentre, Randomised, Double-Blind, Parallel-Group Study to Compare the Efficacy and Safety of Fluticasone Propionate 1mg bd (2mg Daily) Administered by Pressurised Inhaler with that of Fluticasone Propionate 1mg bd (2mg Daily) Administered as a Dry Powder Via a Diskhaler Inhaler and an Ope ...
FMS30058 Completed A multicenter, randomized, double-blind, parallel group, placebo-controlled, 12 week study of Fluticasone Propionate 44mcg BID and 88mcg BID delivered via CFC MDI and a valved holding chamber with facemask in subjects with asthma age 24 months to 47 months Study Listed on ClinicalStudyDataRequest.com
FMS30059 Completed A multicenter, randomized, double-blind, parallel group, placebo-controlled, 12 week study of Fluticasone Propionate 44mcg BID and 88mcg BID delivered via CFC MDI and a valved holding chamber with facemask in subjects with asthma age 6 months to 2 years Study Listed on ClinicalStudyDataRequest.com
FMS30060 Completed Anti-inflammatory treatment of infants with persistent dyspnoea (Early Wheezing).
FMS40001 Completed A randomised, double-blind, double-dummy, parallel group, multicentre study to compare the effect on growth measured by stadiometry of fluticasone propionate (100µg bd) administered via DISKUS™ with budesonide (200µg bd) administered via Turbuhaler in prepubescent children. Study Listed on ClinicalStudyDataRequest.com
FMS40010 Completed Comparing the efficacy of the antileukotriene montelukast to fluticasone 200µg in steroid naïve subjects with mild to moderate asthma.
FMS40012 Completed Evaluation of the potential anti-inflammatory action of Leukotriene D4 receptor antagonists: comparison of Zafirlukast, an LDT4 receptor antagonist with low-dose fluticasone propionate, an inhaled steroid on sputum eosinophils in mild asthma
FMS40038 Completed A randomized, double-blind, placebo-controlled, parallel-group study to assess the equivalence of fluticasone propionate 100mcg BID via MDI, formulated with 1% and 10% lecithin
FMS40049 Completed Multi-centre, randomised, double-blind, parallel-group study to determine the clinical equivalence between fluticasone propionate 500?g once daily and fluticasone propionate 250?g twice daily, both delivered via the metered-dose-inhaler (MDI) in patients with moderate asthma.
FMS40121 Completed A double blind, parallel group, two way study to compare a high starting dose of fluticasone (1000 µg/day) tapering off to a low maintenance dose (100 µg/day) and a continuous intermediate dose (200 µg/day) in asthmatic children aged 6 to 10 years.
FMS40137 Completed A Randomized, Double-Blind, Parallel-Group, Comparative Trial Assessing the Long Term Safety of Inhaled Fluticasone Propionate Rotadisks Via Diskhaler 50mcg BID and 100mcg BID Versus Placebo in Patients Aged 4 to 11 Years with Mild to Moderate Chronic Asthma
FMS40163 Completed Effect of fourteen weeks treatment with fluticasone propionate step-down dosing from 1000mcg/day in comparison with a fixed dose of 200mcg/day followed by an open phase with placebo administered for 8 weeks in subjects with mild asthma who exacerbate during treatment with beta-2 agonist (prn).
FMS40166 Completed A general practice, single-centre, randomised, double-blind, placebo controlled parallel group study to determine the effect of 2 weeks treatment with fluticasone propionate 2 x 250 mcg bd MDI via Volumatic spacer in patients with persistent cough and/or acute bronchitis.
FMS40175 Completed Effect of long-term treatment with fluticasone propionate on bone density, growth and lung function in childhood asthma.
FMS40180 Completed A placebo controlled trial studying the effect of a single dose inhaled fluticasone propionate on the bronchial diameter and the severity of exercise-induced asthma.Extensive searching has revealed that no clinical report is available for this study.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.